feed,title,long_url,short_url
Benzinga,"Neoleukin Pauses Development Of NL-201, Cuts 40% Of Employee Strength",https://benzinga.com/general/biotech/22/11/29725517/neoleukin-pauses-development-of-nl-201-cuts-40-of-employee-strength,https://bit.ly/3Gd5a7E
